Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling

Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling

Phosphatidylserines are known to sustain skeletal muscle activity during intense activity or hypoxic conditions, as well as preserve neurocognitive function in older patients. Our previous studies pointed out a potential cardioprotective role of phosphatidylserine in heart ischemia. Therefore, we in...

Full description

Bibliographic Details
Main Authors: David Schumacher, Adelina Curaj, Mareike Staudt, Franziska Cordes, Andreea R. Dumitraşcu, Benjamin Rolles, Christian Beckers, Josefin Soppert, Mihaela Rusu, Sakine Simsekyilmaz, Kinan Kneizeh, Chrishan J. A. Ramachandra, Derek J. Hausenloy, Elisa A. Liehn
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
L-α-Phosphatidyl-L-serine
phosphatidylserine
myocardial infarction
cardio-protection
preconditioning
inflammation
Online Access:https://www.mdpi.com/1422-0067/22/9/4401

Internet

https://www.mdpi.com/1422-0067/22/9/4401

Similar Items